Ignite Creation Date:
2024-05-06 @ 2:21 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02026648
Status:
COMPLETED
Last Update Posted:
2016-09-07
First Post:
2014-01-01
Brief Title:
Outcome of Women With Cervical Cancer
Sponsor:
Far Eastern Memorial Hospital
Organization:
Far Eastern Memorial Hospital
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2016-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Squamous cell carcinoma SCC of the cervix has showed a marked decline in developed countries over the past 40 years however there has also been an increase in relative and absolute incidence of adenocarcinoma and adenosquamous carcinoma AC of the uterine cervix over the same period
Our understanding of the natural history and optimal management of AC is limited It appears that AC and SCC of the cervix behave differently They are different in epidemiology prognostic factors and patterns of failure after similar treatments Available data suggest that they may also differ in their response to treatment We postulate that new treatment strategies specifically tailored to AC should be explored
However there is few data about outcome of cervical cancer in Taiwan So we propose this proposal for retrospective analysis of clinicopathological parameters and outcomes in patients of cervical cancer especially for cervical adenocarcinoma and adenosquamous carcinoma
Our understanding of the natural history and optimal management of AC is limited It appears that AC and SCC of the cervix behave differently They are different in epidemiology prognostic factors and patterns of failure after similar treatments Available data suggest that they may also differ in their response to treatment We postulate that new treatment strategies specifically tailored to AC should be explored
However there is few data about outcome of cervical cancer in Taiwan So we propose this proposal for retrospective analysis of clinicopathological parameters and outcomes in patients of cervical cancer especially for cervical adenocarcinoma and adenosquamous carcinoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None